LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $18,142,791
Key CONT_AWD_75N91022F00024_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 670 days before this system saw it. One version on record.
Cite this row
313a97a187b84d02f28b1d968e666e416faa2b8f6881c28ef66dd5848b7098c5The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $18,142,791 | first version | September 16, 2022 | November 4, 2024 | 2026-09-05T00:54:52Z | historical sweep | 313a97a187b8 |
Archived copy
None on file. An archived copy is optional corroboration and never a condition of this filing’s provenance, which is the stored response and its hash above; see the methodology page.
What the amount is made of
4 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $18,142,791.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| November 4, 2024 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | NIAID-DMID MONKEYPOX VACCINE CLINICAL TRIAL - JYNNEOS DOSE SPARING TRIAL |
| June 30, 2023 | P00002 | OTHER ADMINISTRATIVE ACTION | +$1,100,557 | NIAID-DMID MONKEYPOX VACCINE CLINICAL TRIAL - JYNNEOS DOSE SPARING TRIAL |
| March 10, 2023 | P00001 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | +$5,544,628 | NIAID-DMID MONKEYPOX VACCINE CLINICAL TRIAL - JYNNEOS DOSE SPARING TRIAL |
| September 16, 2022 | base | not on file | +$11,497,606 | NIAID-DMID MONKEYPOX VACCINE CLINICAL TRIAL - JYNNEOS DOSE SPARING TRIAL |
Last refreshed November 4, 2026 at 2:31 PM UTC.